Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Aug 9;10(3):127. doi: 10.3390/pharmaceutics10030127

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Other Potent MDR reversal agents. (a) Compound 26. (1S,2S,3S,4S,7R,9R,13R,14R,15S)-9,15-Fiacetoxy-3,7-dibenzoyloxy-1,13,14-trihydroxyjatropha-5E-ene [55]. (b) GO-Y078. (1E,4E)-1-(4-hydroxy-3,5-dimethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)penta-1,4-dien-3-one [29]. (c) Compound 51. (2R,3S)-5,7-Dimethoxy-2-(3,4,5-trimethoxyphenyl)chroman-3-yl. 3-(3,4,5-trimethoxybenzamido)-4-fluorobenzoate [56]. (d) Compound 4e. 1,16-Bis[40-((6-methyl)-4H-chromen-4-on-2-yl)phenyl]-1,4,7,10, 13,16-hexaoxahexadecane [56].